Company News »

Burt Zweigenhaft to Retire from Onco360

Business Wire
Share on StockTwits
Published on

Onco360, one of the nation’s largest independent providers of oncology pharmacy services, announced today that Burt Zweigenhaft will be retiring from Onco360 on May 8, 2015. As an early founder, Mr. Zweigenhaft has been a driving force of Onco360 for the past nine years, and has built the Company’s reputation as a provider of high quality Oncology Pharmacy services for cancer patients. During his tenure with Onco360, the Company has grown from a local Oncology Pharmacy serving patients in the metropolitan New York area, to a national provider servicing thousands of cancer patients across the United States.

“As a veteran of the pharmacy healthcare industry for over thirty years, I am most proud of what we have been able to accomplish with Onco360. Moving the needle to provide best practices in care for cancer patients has been my passion since joining the Company, and to see this passion for what we do resonate and become industry standard in the national cancer care marketplace, has been extremely fulfilling for me.” Mr. Zweigenhaft stated. “As the Company continues its promising growth, I am fully confident in the direction and leadership of Onco360 as it enters the next phase of its extraordinary development,” Mr. Zweigenhaft went on to say.

“Burt leaves a legacy of a unique business model and high-performing organization adding value to the healthcare system through its support of patients suffering from highly complex diseases. We will continue to build on the great clinical, operational, and customer service assets that Onco360 has become known for in the industry. I want to personally thank Burt for his leadership, commitment, and loyalty over the past 9 years,” said Paul Jardina, Onco360 President and CEO.

Mr. Zweigenhaft will continue to stay involved in industry leadership roles serving as Co-Chairman of the Association of Value Based Cancer Care, Vice President of the National Specialty Pharmacy Association and continuing philanthropically to serve as a Board Member of Swim Across America for Cancer funding cancer research.

About Onco360(R) Oncology Pharmacy:

Onco360 ( is one of the largest independent providers of Oncology Pharmacy services in the country. Onco360 was founded in 2003 to bring together the stakeholders involved in the cancer treatment process and serve the specialized needs of oncologists, patients, hospitals, cancer centers of excellence, manufacturers, health plans, and payers. The Company’s clinical and dispensing model was developed specifically to meet the unique needs of oncology-treating physicians and their patients. Onco360 is advancing the continuum of oncology pharmaceutical care through patient advocacy, dispensing excellence, and the clinical experience and expertise that comes from its focus in oncology. Onco360 is headquartered in Louisville, KY and dispenses nationally through its network of JCAHO-accredited Oncology Pharmacies. PharMerica Corporation (NYSE:PMC) , a leading institutional pharmacy, specialty infusion and hospital services company servicing healthcare facilities in the United States, made a significant strategic investment in Onco360 in December 2013.

Share on StockTwits